SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
SEC Accession No. 0000078003-18-000020
Filing Date
2018-02-13
Accepted
2018-02-13 17:23:00
Documents
2
Group Members
C. P. PHARMACEUTICALS INTERNATIONAL C.V.PFIZER MANUFACTURING LLCPFIZER PRODUCTION LLC

Document Format Files

Seq Description Document Type Size
1 SCHEDULE 13G AMENDMENT 1 protalix13ga1.htm SC 13G/A 32560
2 EXHIBIT 99.1 protalixexh99.htm EX-99.1 5471
  Complete submission text file 0000078003-18-000020.txt   40012
Mailing Address 235 E 42ND ST NEW YORK NY 10017
Business Address 235 E 42ND ST NEW YORK NY 10017 2125732323
PFIZER INC (Filed by) CIK: 0000078003 (see all company filings)

IRS No.: 135315170 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G/A
SIC: 2834 Pharmaceutical Preparations

Mailing Address 2 SNUNIT ST SCIENCE PARK, POB 455 CARMIEL L3 20100
Business Address 2 SNUNIT ST SCIENCE PARK, POB 455 CARMIEL L3 20100 972-4-988-9488
Protalix BioTherapeutics, Inc. (Subject) CIK: 0001006281 (see all company filings)

IRS No.: 650643773 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G/A | Act: 34 | File No.: 005-50118 | Film No.: 18604986
SIC: 2836 Biological Products, (No Diagnostic Substances)